Duke University

Category

Rush Medical Center Initiates HERO-HCQ Study in Chicago: Will Hydroxychloroquine Help Protect Healthcare Workers from COVID-19?

Rush University Medical Center opened up enrollment for the HERO-HCQ clinical trial to determine whether hydroxychloroquine is better than a placebo in preventing COVID-19 in healthy people working in a health care setting. With its full title as the Healthcare Worker...

Vanderbilt & Williamson Medical Center of TN Join HERO Study & Accelerate Enrollment of Health Workers for Prevention of COVID-19

Both Vanderbilt Medical Center and Williamson Medical Center have joined the Healthcare Worker Exposure Response and Outcomes (HERO) clinical trial, a federally-supported research effort investigating the effectiveness of plaquenil hydroxychloroquine in preventing the...

University Hospitals Seidman Cancer Center Treats its First Glioblastoma Patient with Duke-Originated Genetically Modified Polio Virus

University Hospitals Seidman Cancer Center (UH) treated its first patient in a new clinical trial to validate groundbreaking effects of poliovirus on glioblastoma (GBM), a deadly Grade IV cancer of the brain. UH was the only Midwest site that participated in this...

Pin It on Pinterest